$37.63
0.61% today
Nasdaq, Sep 16, 07:08 pm CET
ISIN
US98419J2069
Symbol
XOMA

XOMA Corporation Stock price

$37.86
+6.49 20.69% 1M
+17.13 82.63% 6M
+11.58 44.06% YTD
+9.26 32.38% 1Y
+19.59 107.23% 3Y
+17.10 82.37% 5Y
+20.54 118.64% 10Y
-499.14 92.95% 20Y
Nasdaq, Closing price Mon, Sep 15 2025
+0.44 1.18%
ISIN
US98419J2069
Symbol
XOMA
Industry

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$30.0m
Cash
$83.9m
Shares outstanding
12.1m
Valuation (TTM | estimate)
P/E
negative | 104.1
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
37.0%
Return on Equity
-23.6%
ROCE
4.7%
ROIC
-
Debt/Equity
1.2
Financials (TTM | estimate)
Revenue
$45.0m | $53.8m
EBITDA
$11.0m | $27.8m
EBIT
$9.5m | $17.9m
Net Income
$-17.7m | $4.4m
Free Cash Flow
$-23.0m
Growth (TTM | estimate)
Revenue
168.7% | 88.9%
EBITDA
148.6% | 628.4%
EBIT
141.6% | 427.0%
Net Income
42.2% | 122.8%
Free Cash Flow
-178.3%
Margin (TTM | estimate)
Gross
-
EBITDA
24.4% | 51.7%
EBIT
21.2%
Net
-39.4% | 8.2%
Free Cash Flow
-51.3%
More
EPS
$-1.0
FCF per Share
$-1.9
Short interest
2.9%
Employees
13
Rev per Employee
$2.2m
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a XOMA Corporation forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a XOMA Corporation forecast:

Buy
80%
Hold
20%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
45 45
169% 169%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
18% 18%
69%
- Research and Development Expense 3.04 3.04
138% 138%
7%
11 11
149% 149%
24%
- Depreciation and Amortization 1.41 1.41
220% 220%
3%
EBIT (Operating Income) EBIT 9.54 9.54
142% 142%
21%
Net Profit -18 -18
42% 42%
-39%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
13 days ago
EMERYVILLE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will present a company update at the H.C. Wainwright 27th Annual Global Investment Conference.
Neutral
GlobeNewsWire
27 days ago
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator (“XOMA Royalty”), announced today they have entered into a definitive agreement pursuant to which XRA 5 Corp., a newly formed company wholly owned...
Neutral
GlobeNewsWire
about one month ago
Business development : Purchased mezagitamab royalty and milestone rights held by BioInvent International and will secure royalty economic interests in two early-stage partnered assets through XOMA Royalty's recently announced acquisition of LAVA Therapeutics.
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website www.xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today